Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates & working
1.2.1 Data collection
1.3 Forecast calculations
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Arbovirus testing industry 360° synopsis, 2018 - 2032 (USD Million)
2.2 Business trends
2.3 Regional trends
2.4 Test type trends
2.5 End-use trends
Chapter 3 Arbovirus Testing Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence rate of arthropod-borne viral diseases
3.2.1.2 Technological advancements in testing products
3.2.1.3 Availability of rapid serology tests in developed countries
3.2.1.4 Increasing investment towards R&D by biopharmaceutical companies
3.2.2 Industry pitfalls & challenges
3.2.2.1 Scarcity of in-vitro facilities
3.2.2.2 Lack of awareness and limited availability of diagnostic testing procedures in some developing counties
3.3 Growth potential analysis
3.3.1 By test type
3.3.2 By end-use
3.4 COVID-19 impact analysis
3.5 Technology landscape
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive dashboard, 2022
4.4 Company market share analysis, 2022
4.5 Competitive analysis of major market players
4.6 Competitive positioning matrix
4.7 Strategic outlook matrix
Chapter 5 Arbovirus Testing Market Size and Forecast, By Test Type (USD Million)
5.1 Key trends, by test type
5.2 ELISA-based tests
5.3 RT-PCR based tests
5.4 Others
Chapter 6 Arbovirus Testing Market Size and Forecast, By End-use (USD Million)
6.1 Key trends, by end-use
6.2 Hospitals
6.3 Diagnostic centers
6.4 Public health laboratory
6.5 Others
Chapter 7 Arbovirus Testing Market Size and Forecast, By Region (USD Million)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Belgium
7.3.7 The Netherlands
7.3.8 Switzerland
7.3.9 Poland
7.3.10 Sweden
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 New Zealand
7.4.7 Thailand
7.4.8 Singapore
7.4.9 Vietnam
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Colombia
7.5.5 Chile
7.6 Middle East & Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Turkey
Chapter 8 Company Profiles
8.1 Agilent Technologies Inc.
8.2 Thermo Fisher Scientific
8.3 NovaTec Immundiagnostica GmbH
8.4 Euroimmun AG
8.5 Abbott Laboratories
8.6 DiaSorin SpA
8.7 QIAGEN N.V.
8.8 Fluke Biomedical
8.9 Copley Scientific
8.10 Distek
8.11 Becton, Dickinson and Company
8.12 Merck KGaA
8.13 Bio-Rad Laboratories
8.14 F. Hoffmann La Roche Ltd.
8.15 Siemens Healthineers AG
